Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients
| dc.contributor.author | Montero Magalló, Paula | |
| dc.contributor.author | Pérez Leal, Martín | |
| dc.contributor.author | Pérez Fidalgo, J. A. | |
| dc.contributor.author | Sanz, Celia | |
| dc.contributor.author | Estornut Navarro, Cristina | |
| dc.contributor.author | Roger Laparra, Inés | |
| dc.contributor.author | Milara, Javier | |
| dc.contributor.author | Cervantes, Andrés | |
| dc.contributor.author | Cortijo, Julio | |
| dc.date.accessioned | 2022-03-03T14:54:07Z | |
| dc.date.available | 2022-03-03T14:54:07Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Skin toxicity is one of paclitaxel’s adverse effects. However, its real impact on the skin could be underestimated as these alterations can also appear asymptomatic. We have observed that paclitaxel modifies gene and protein expression of skin markers in a 3D epidermis model, and impairs physical, physiological, and biomechanical properties of the skin in gynecologic cancer patients. These subclinical alterations might be avoided by using prophylactic measures during treatment to prevent possible future adverse reactions. | spa |
| dc.description.filiation | UEV | spa |
| dc.description.impact | 5.2 Q2 JCR 2022 | spa |
| dc.description.impact | 1.312 Q1 SJR 2022 | spa |
| dc.description.impact | No data IDR 2022 | spa |
| dc.description.sponsorship | Fondo Europeo de Desarrollo Regional (FEDER) | spa |
| dc.description.sponsorship | Instituto de Salud Carlos III (PI20/01363) | spa |
| dc.description.sponsorship | Gobierno de España, CIBERES (CB06/06/0027) | spa |
| dc.description.sponsorship | Generalitat Valenciana, Prometeo (2017/023/UV) | spa |
| dc.identifier.citation | Montero, P., Pérez-Leal, M., Pérez-Fidalgo, J. A., Sanz, C., Estornut, C., Roger, I., Milara, J., Cervantes, A., & Cortijo, J. (2022). Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients. Cancers, 14(5), 1146. https://doi.org/10.3390/cancers14051146 | spa |
| dc.identifier.doi | 10.3390/cancers14051146 | |
| dc.identifier.issn | 2072-6694 | |
| dc.identifier.uri | http://hdl.handle.net/11268/10881 | |
| dc.language.iso | eng | spa |
| dc.peerreviewed | Si | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.accessRights | open access | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject.other | Oncología | spa |
| dc.subject.other | Dermatologia | spa |
| dc.subject.other | Ginecología | spa |
| dc.subject.other | Quimioterapia | spa |
| dc.subject.unesco | Farmacología | spa |
| dc.subject.unesco | Cáncer | spa |
| dc.subject.unesco | Enfermedad de la piel | spa |
| dc.subject.unesco | Salud de la mujer | spa |
| dc.title | Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients | spa |
| dc.type | journal article | spa |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Cancers-14-01146.pdf
- Size:
- 3.42 MB
- Format:
- Adobe Portable Document Format
- Description:
- Versión del editor

